Online Only Articles

Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and major

Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia (CHOP), PA, USA
Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia (CHOP), PA, USA
Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia (CHOP), PA, USA;Penteli’s Children’s Hospital, Pediatric Department, Athens, Greece
Adaptimmune Therapeutics Ltd., Abingdon, UK
Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia (CHOP), PA, USA
Novartis Pharma AG, Basel, Switzerland
Department of Pediatrics, Division of Hematology, Children’s Hospital of Philadelphia (CHOP), PA, USA
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.181511